[First experience using an aromatase inhibitor in combination with growth hormone to improve growth prognosis in a 14-year-old boy with growth hormone deficiency after treatment of craniopharyngioma. A case-report]. [PDF]
Probl Endokrinol (Mosk)Mazerkina NA +4 more
europepmc +1 more source
[Alemtuzumab-induced Graves' disease]. [PDF]
Probl Endokrinol (Mosk), 2023 Sheremeta MS +6 more
europepmc +1 more source
[Efficacy of standard methods in the treatment of prolactin-secreting pituitary carcinoma]. [PDF]
Probl Endokrinol (Mosk)Astafyeva LI +4 more
europepmc +1 more source
[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review]. [PDF]
Probl Endokrinol (Mosk), 2023 Ishmuratova AN +14 more
europepmc +1 more source
[The role of an interdisciplinary approach to the treatment of patients with reduced ovarian reserve, premature ovarian insufficiency and mood disorders]. [PDF]
Probl Endokrinol (Mosk)Absatarova YS +5 more
europepmc +1 more source
[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation]. [PDF]
Probl Endokrinol (Mosk)Simanenkova AV +7 more
europepmc +1 more source
[Cephalgic syndrome in patients with acromegaly]. [PDF]
Probl Endokrinol (Mosk)Nurullina GN +2 more
europepmc +1 more source
[Hepatogenic diabetes: three cases report and literature review]. [PDF]
Probl Endokrinol (Mosk)Amosova MV +4 more
europepmc +1 more source
[Hypophisitis in pregnant women with persistent diabetes insipidus in the outcome]. [PDF]
Probl Endokrinol (Mosk)Dzeranova LK +3 more
europepmc +1 more source
[Hyperparathyroidism of different genesis in young patients with Turner syndrome: case series and brief review]. [PDF]
Probl Endokrinol (Mosk)Ozhimalov ID +7 more
europepmc +1 more source